Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/16299
Title: Image guidance and stabilization for stereotactic ablative body radiation therapy (SABR) treatment of primary kidney cancer
Authors: Pham, Daniel;Kron, Tomas;Bressel, Mathias;Foroudi, Farshad;Hardcastle, Nicholas;Schneider, Michal;Soteriou, Sally;Innes, Jayson;Siva, Shankar
Issue Date: Nov-2015
EDate: 2015-08-20
Citation: Practical Radiation Oncology 2015; 5(6): e597-e605
Abstract: PURPOSE: Stereotactic ablative body radiation therapy for primary kidney cancer treatment relies on motion management that can quantify both the trajectory of kidney motion and stabilize the patient. A prospective ethics-approved clinical trial of stereotactic treatment to primary kidney targets was conducted at our institution. Our aim was to report on specific kidney tumor motion and the inter- and intrafraction motion as seen on treatment. METHODS AND MATERIALS: Patients with tumor size <5 cm received a dose of 26 Gy in 1 fraction and those with tumor size ≥5 cm received 42 Gy in 3 fractions. All patients underwent a 4-dimensional computed tomography planning scan, immobilized in a dual-vacuum system. A conventional linear accelerator cone beam computed tomography scan was used for pre-, mid-, and posttreatment imaging to verify target position. RESULTS: Between July 2012 and October 2014, 33 targets from 32 consecutive patients (24 males/8 females) were treated. Seventeen targets were prescribed 26 Gy/1 fraction and the remaining 16 targets received 42 Gy/3 fractions. Kidney motion at each of the poles was not affected by the presence of tumor (P = .875), nor was the motion statistically different from the corresponding contralateral kidney pole (P = .909). The mean 3-dimensional displacement of the target at mid- and posttreatment was 1.3 mm (standard deviation ± 1.6) and 1.0 mm (standard deviation ± 1.3), respectively. The maximum displacement in any direction for 95% of the fractions at mid- and posttreatment was ≤3 mm. CONCLUSION: In summary, stereotactic ablative body radiation therapy of primary kidney targets can be accurately delivered on a conventional linear accelerator with protocol that has minimal intrafractional target motion.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16299
DOI: 10.1016/j.prro.2015.08.002
PubMed URL: http://www.ncbi.nlm.nih.gov/pubmed/26547828
Type: Journal Article
Subjects: Kidney Neoplasms
Movement
Radiosurgery
Respiratory-Gated Imaging Techniques
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.